diphenyleneiodonium has been researched along with Sclerosis, Systemic in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dosoki, H | 1 |
| Stegemann, A | 1 |
| Taha, M | 1 |
| Schnittler, H | 1 |
| Luger, TA | 1 |
| Schröder, K | 1 |
| Distler, JH | 1 |
| Kerkhoff, C | 1 |
| Böhm, M | 1 |
1 other study available for diphenyleneiodonium and Sclerosis, Systemic
| Article | Year |
|---|---|
Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
Topics: Actins; Adult; Animals; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Computer S | 2017 |